Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

MTP inhibitors from Bristol-Myers Squibb

Oct. 11, 1996

Neurex and Beaufour Ipsen reach licensing agreement for Corlopam

Oct. 11, 1996

Wakunaga discloses angiotensin II antagonists

Oct. 11, 1996

Endothelin antagonists from Banyu

Oct. 11, 1996

Warner-Lambert claims endothelin antagonists

Oct. 11, 1996

Further patent coverage for vascular disease therapy

Oct. 4, 1996

New bi-ventricular pacemaker enters clinical trials

Oct. 4, 1996

HemoCleanse evaluates sorbent-based system in sepsis

Oct. 4, 1996

T Cell Sciences receives grant to develop CETP vaccine

Oct. 4, 1996

Alexion authorized to begin second clinical trial with C5 inhibitor

Oct. 4, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...